- Home
- OMH vs AZTR Comparison
OMH vs AZTR Comparison
Compare OMH & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- AZTR
- Stock Information
- Founded
- OMH 2015
- AZTR 2014
- Country
- OMH Singapore
- AZTR United States
- Employees
- OMH N/A
- AZTR N/A
- Industry
- OMH Real Estate
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- AZTR Health Care
- Exchange
- OMH Nasdaq
- AZTR Nasdaq
- Market Cap
- OMH N/A
- AZTR 5.2M
- IPO Year
- OMH 2023
- AZTR 2023
- Fundamental
- Price
- OMH $2.23
- AZTR $0.30
- Analyst Decision
- OMH Strong Buy
- AZTR
- Analyst Count
- OMH 1
- AZTR 0
- Target Price
- OMH $15.00
- AZTR N/A
- AVG Volume (30 Days)
- OMH 17.0K
- AZTR 280.4K
- Earning Date
- OMH 01-01-0001
- AZTR 05-08-2025
- Dividend Yield
- OMH N/A
- AZTR N/A
- EPS Growth
- OMH N/A
- AZTR N/A
- EPS
- OMH N/A
- AZTR N/A
- Revenue
- OMH $5,390,607.00
- AZTR $7,500.00
- Revenue This Year
- OMH $111.47
- AZTR N/A
- Revenue Next Year
- OMH $32.08
- AZTR N/A
- P/E Ratio
- OMH N/A
- AZTR N/A
- Revenue Growth
- OMH 25.77
- AZTR N/A
- 52 Week Low
- OMH $0.25
- AZTR $0.23
- 52 Week High
- OMH $2.70
- AZTR $12.00
- Technical
- Relative Strength Index (RSI)
- OMH 63.38
- AZTR 39.89
- Support Level
- OMH $2.12
- AZTR $0.28
- Resistance Level
- OMH $2.31
- AZTR $0.35
- Average True Range (ATR)
- OMH 0.23
- AZTR 0.03
- MACD
- OMH -0.07
- AZTR -0.00
- Stochastic Oscillator
- OMH 25.34
- AZTR 34.45
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.